Core Insights - MiMedx Group, Inc. will report its operating and financial results for Q3 2025 on October 29, 2025, after market close [1] - A conference call and webcast will be held at 4:30 p.m. Eastern Time on the same day to discuss the results [1] Company Overview - MiMedx is a pioneer in healing solutions, focusing on chronic and hard-to-heal wounds with over a decade of experience [2] - The company aims to be the leading global provider of healing solutions through continuous innovation [2]

Group 1 - MiMedx Group, Inc. will present six posters showcasing its latest product innovations at the Symposium on Advanced Wound Care (SAWC) Fall meeting from September 3-6, 2025, in Las Vegas, NV [1][3] - The company aims to highlight its advanced wound care portfolio at booth 511 during the SAWC event, which is a key platform for clinicians and industry professionals [1] - The company has a vision to be the leading global provider of healing solutions through relentless innovation, focusing on chronic and hard-to-heal wounds [4] Group 2 - A sponsored lunch symposium titled "Change is Inevitable: Mastering the Art of Wound Healing in an Evolving Landscape" will take place on September 4, 2025, featuring discussions on advanced treatment approaches for diverse patient populations [2] - The symposium will include presentations by notable faculty members, addressing the complexities and challenges in wound care [2]

Adia Med Surges Ahead of Growth Timeline With Venture Medical Partnership in $25B Wound Care MarketAugust 26, 2025 8:00 AM EDT | Source: Adia Nutrition Inc.Winter Park, Florida--(Newsfile Corp. - August 26, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a bold leader in regenerative medicine and personalized healthcare, today announced a thrilling partnership between its clinical division, Adia Med, and Venture Medical. This electrifying collaboration launches Adia Med into the epicenter of insura ...

Group 1 - MiMedx Group, Inc. will report its operating and financial results for Q2 2025 on July 30, 2025, after market close [1] - A conference call and webcast will be held at 4:30 p.m. Eastern Time on the same day to discuss the results [1] - The company is a leader in providing healing solutions for chronic and hard-to-heal wounds, with a focus on innovation [2] Group 2 - MiMedx aims to be the leading global provider of healing solutions, enhancing quality of life through its product portfolio [2] - The company has over a decade of experience in the wound care, burn, and surgical sectors of healthcare [2]

Company Overview - MiMedx Group, Inc. is a pioneer in the healthcare sector, focusing on healing solutions for chronic and hard-to-heal wounds [3] - The company has over a decade of experience in providing products for wound care, burn, and surgical applications [3] - MiMedx aims to be the leading global provider of healing solutions through continuous innovation [3] Event Participation - MiMedx's senior management will participate in the BofA Securities 2025 Healthcare Conference in Las Vegas, NV [1] - The presentation is scheduled for May 13, 2025, at 5:15 p.m. PDT [2] - Investors interested in meeting with senior management can contact their Bank of America representative [2]

Company Announcement - MiMedx Group, Inc. will report its operating and financial results for Q1 2025 on April 30, 2025, after market close [1] - A webcast and conference call will be held at 4:30 p.m. Eastern Time on the same day to review the results [1] - The conference call can be accessed by U.S. investors at 877-407-6184 and international investors at 201-389-0877, with a conference ID of 13752696 [1] Company Overview - MiMedx is a pioneer and leader in healing solutions, focusing on chronic and hard-to-heal wounds [2] - The company aims to provide a leading portfolio of products for wound care, burn, and surgical sectors [2] - MiMedx's vision is to be the leading global provider of healing solutions through relentless innovation [2]